GLP-1 drugs made a former FDA chief ‘feel ill.’ But he’d take them again.
David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic disease in the United States.
Month: May 2025
Weight loss drugs have “no end game,” former FDA commissioner warns
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on “CBS Mornings Plus.”
Trump Calls Out Weight-loss Drugs as Target Of Price-cut Push
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its push to lower prescription drug… Reuters Health Information
Wealthy but unhealthy: The American health paradox
President Trump and his administration have promised to “Make America Wealthy Again” and “Make America Healthy Again.” However, despite spending two to four times more per person on health care as other developed countries, the U.S. has higher mortality and worse health outcomes. In short, our expensive health system may simultaneously make us less wealthy … Read more
Lower doses of the GLP-1 agonist medication as effective as higher ones, Danish study finds
New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity clinic achieved similar weight loss to that reported in clinical trials—but with less than half the medication. The study is to be published in the journal The Lancet Digital Health.
Semaglutide may provide early protection against heart disease in high-risk patients
Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or obesity who have pre-existing cardiovascular disease but not diabetes, according to a secondary analysis of the landmark Semaglutide and Cardiovascular Outcomes (SELECT) trial from the same international author team presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May).
Rapid Weight Loss Can Trigger Emotional Turmoil
While GLP-1 receptor agonists and bariatric surgery offer significant metabolic benefits, experts caution that rapid weight loss may trigger emotional instability in vulnerable individuals. Medscape Medical News
GLP-1 Weight Loss Drugs Cut Alcohol Cravings By Two-Thirds
By Dennis Thompson HealthDay ReporterTUESDAY, May 13, 2025 (HealthDay News) — Cutting-edge weight-loss drugs like Ozempic/Wegovy can cut alcohol…
Top 10 most expensive prescription drugs in the US by price and by sales volume
On the heels of President Donald Trump’s Monday announcement of an executive order that will slash prescription drug prices in the U.S., the spotlight is on current costs and how much Americans could save. The president’s order calls for “most favored nations drug pricing” — which means “the lowest price paid for a drug in … Read more